A new study by MiraKind’s Founder, Dr. Joanne Weidhaas, in collaboration with her team at the University of California, Los Angeles and City of Hope, has been published in the scientific journal…
Read More ➝
We had an excellent question from a MiraKind study participant. They wanted to know, “If I participate in a study will you send me my KRAS-variant results?” Unfortunately, the answer is no….
Read More ➝
We received a great question from a friend of a patient asking, “since she knows she has a BRCA mutation, is it necessary to find out if she also has the KRAS-variant?…
Read More ➝
We had an excellent question from a participant who has the KRAS-variant and had chosen to have her ovaries removed. She asked her OB/GYN if she still needed to have pelvic exams…
Read More ➝
As discussed in our previous Genetics series posts, the discovery of non-coding RNAs paved the way for changes in the Central Dogma and how we think about the flow of genetic information…
Read More ➝
Webinar – KRAS-Variant and Breast Cancer Did you miss our live webinar on the KRAS-Variant with Dr. Joanne Weidhaas? Watch the replay and learn about how this genetic mutation can impact your…
Read More ➝
The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we have spoken a…
Read More ➝
Here at MiraKind, we’re constantly inspired by the amazing women who surround us; whether it is scientists and doctors working on our research, or the strong and empowered women who are facing complex health challenges with dignity and grace.
Read More ➝
It’s Breast Cancer Awareness Month, so here at MiraKind, we’re taking a moment to think about the many ways in which breast cancer impacts our community. Many of you may know that…
Read More ➝
Post Updated February 7, 2022 For the large majority of us who suffer one or more symptoms of menopause, we can all agree that it is NO FUN. So what can we…
Read More ➝
Joanne Weidhaas is MiraKind’s founder and one of the scientists responsible for discovering the KRAS-variant, an inherited genetic mutation that predicts an increased risk of cancer. Following this breakthrough, Dr. Weidhaas and…
Read More ➝
Menopause: a condition that 100% of women will experience, yet so few of us feel comfortable talking about. We all know something about menopause, but just like pregnancy or bungee jumping, you…
Read More ➝
Dear study participants, I wanted to share an experience that I had today. I had a wonderful conversation with a woman who participated in the first MiraKind study. While I always enjoy…
Read More ➝
Although much of the world has accepted that GWAS studies, which use an outdated technology looking at large amounts of data, have failed to find any functional mutations, this approach has twice…
Read More ➝
We are embarking on a study to explore how breast cancer management strategies (e.g., chemotherapy, surgery, hormones) that are used to treat breast cancer, impact breast cancer risk for women with the KRAS-variant.
Read More ➝
Disclaimer
Any discussion of medical management options on this website is for general informational purposes only and does not constitute a medical recommendation. All medical management decisions should be made based on consultation between each patient and his or her healthcare professional.
